000 01341 a2200373 4500
005 20250514204007.0
264 0 _c20050421
008 200504s 0 0 eng d
022 _a0171-967X
024 7 _a10.1007/s00223-004-0286-7
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMellström, D D
245 0 0 _aSeven years of treatment with risedronate in women with postmenopausal osteoporosis.
_h[electronic resource]
260 _bCalcified tissue international
_cDec 2004
300 _a462-8 p.
_bdigital
500 _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aBone Density
_xdrug effects
650 0 4 _aEtidronic Acid
_xanalogs & derivatives
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aOsteoporosis, Postmenopausal
_xdrug therapy
650 0 4 _aRadiography
650 0 4 _aRisedronic Acid
650 0 4 _aSpinal Fractures
_xdiagnostic imaging
700 1 _aSörensen, O H
700 1 _aGoemaere, S
700 1 _aRoux, C
700 1 _aJohnson, T D
700 1 _aChines, A A
773 0 _tCalcified tissue international
_gvol. 75
_gno. 6
_gp. 462-8
856 4 0 _uhttps://doi.org/10.1007/s00223-004-0286-7
_zAvailable from publisher's website
999 _c15147442
_d15147442